Quantitative assessment shows loss of antigenic epitopes as a function of pre-analytic variables

Yalai Bai1, Juliana Tolles, Huan Cheng

  • 1Department of Pathology, Yale University School of Medicine, New Haven, CT, USA.

Insights

Cold ischemic time significantly impacts protein detection in tissue samples. Core needle biopsies offer more accurate biomarker assessment than tumor resections due to minimal pre-analytic variable effects.

Area of Science:

  • Biomarker analysis
  • Immunohistochemistry
  • Pre-analytic variable research

Background:

  • Pre-analytic variables, particularly cold ischemic time, are known to affect protein measurements in immunohistochemistry.
  • Assessing antigenic loss is crucial for accurate biomarker quantification.

Purpose of the Study:

  • To quantify the impact of pre-analytic variables on protein antigenicity.
  • To compare protein antigenicity between core needle biopsies and tumor resections.

Main Methods:

  • Quantitative immunofluorescence (AQUA® method) was used.
  • Two cohorts of matched core needle biopsies and tumor resections were analyzed.
  • Epitopes including phospho-ERK, total ERK, phospho-AKT, total AKT, phospho-S6K1, total S6K1, estrogen receptor (ER), Ki67, cytokeratin, and GAPDH were assessed.

Main Results:

  • Significantly decreased detection levels for all phospho-epitopes in tumor resections compared to biopsies.
  • No significant change observed in corresponding total proteins.
  • Significant loss of antigenicity for estrogen receptor (ER) and cytokeratin in resections.

Conclusions:

  • Pre-analytic variables, especially cold ischemic time, dramatically affect phospho-protein antigenicity measurement in formalin-fixed tissues.
  • Core needle biopsies provide a more accurate assessment of tissue biomarkers compared to tumor resections.